We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.4% |
| 2 | Miscellaneous | 13.92% |
| 3 | Consumer Discretionary | 5.42% |
| 4 | Energy | 4.31% |
| 5 | Financials | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRF
676
DELISTED
INTL RECTIFIER CORP
IRF
| $287K | ﹤0.01% |
10,447
-21,197
| -67% | -$563K |
|
677
National Fuel Gas
NFG
$7.64B
| $286K | ﹤0.01% |
4,078
-6,820
| -63% | -$499K |
|
678
Commercial Metals
CMC
$7.28B
| $285K | ﹤0.01% |
15,088
-17,949
| -54% | -$349K |
|
679
Starbucks
SBUX
$111B
| $285K | ﹤0.01% |
7,744
-12,878
| -62% | -$476K |
|
|
NAV
680
DELISTED
Navistar International
NAV
| $283K | ﹤0.01% |
8,349
-536
| -6% | -$19K |
|
681
Mastercard
MA
$497B
| $282K | ﹤0.01% |
3,765
-5,315
| -59% | -$415K |
|
|
P
682
DELISTED
Pandora Media Inc
P
| $282K | ﹤0.01% |
+9,289
| New | +$322K |
|
683
Cognex
CGNX
$10.1B
| $280K | ﹤0.01% |
+16,480
| New | +$308K |
|
|
FCS
684
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $279K | ﹤0.01% |
20,169
-6,802
| -25% | -$90.9K |
|
685
Motorola Solutions
MSI
$76.2B
| $278K | ﹤0.01% |
+4,311
| New | +$282K |
|
686
News Corp Class B
NWS
$17.9B
| $278K | ﹤0.01% |
+16,600
| New | +$282K |
|
687
Vishay Intertechnology
VSH
$4.8B
| $277K | ﹤0.01% |
18,607
-670
| -3% | -$9.41K |
|
|
HSP
688
DELISTED
HOSPIRA INC
HSP
| $277K | ﹤0.01% |
6,400
-50,299
| -89% | -$2.16M |
|
689
NCR Voyix
VYX
$982M
| $276K | ﹤0.01% |
12,290
-1,663
| -12% | -$35.3K |
|
|
WIN
690
DELISTED
Windstream Holdings Inc
WIN
| $276K | ﹤0.01% |
+4,271
| New | +$265K |
|
691
Boyd Gaming
BYD
$5.49B
| $275K | ﹤0.01% |
20,820
-11,971
| -37% | -$139K |
|
692
Louisiana-Pacific
LPX
$4.57B
| $275K | ﹤0.01% |
16,258
-16,307
| -50% | -$286K |
|
693
Semtech
SMTC
$15.6B
| $275K | ﹤0.01% |
10,829
-1,962
| -15% | -$47.8K |
|
694
Visa
V
$693B
| $274K | ﹤0.01% |
5,072
-4,128
| -45% | -$229K |
|
|
CADE
695
DELISTED
Cadence Bank
CADE
| $273K | ﹤0.01% |
+10,932
| New | +$266K |
|
696
Domino's
DPZ
$9.97B
| $273K | ﹤0.01% |
+3,535
| New | +$261K |
|
697
Marathon Petroleum
MPC
$116B
| $272K | ﹤0.01% |
6,244
-41,648
| -87% | -$1.83M |
|
|
SAVE
698
DELISTED
Spirit Airlines, Inc.
SAVE
| $271K | ﹤0.01% |
+4,554
| New | +$239K |
|
|
MWV
699
DELISTED
MEADWESTVACO CORP
MWV
| $271K | ﹤0.01% |
7,193
-2,116
| -23% | -$77K |
|
|
JOY
700
DELISTED
Joy Global Inc
JOY
| $270K | ﹤0.01% |
4,638
-2,771
| -37% | -$154K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management's Q1 2014 filing shows 297 new, 261 increased, 271 reduced and 313 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M. The largest sale was Allergan Inc, an estimated $286M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 57% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.